The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review.

Odysseas VioletisPanagiota KonstantakouAriadni Spyroglou Antonios XydakisPanagiotis B KekisSofia TseleniDenise KolomodiManousos KonstadoulakisMastorakos GeorgeMaria TheochariJavier AllerKrystallenia I Alexandraki

Published in: Journal of personalized medicine (2024)

Our case, together with the systematic review, imply that a combination of molecular-targetedtreatments may be safe and effective in patients with RAI-resistantBRAF-mutated advanced PDTC when surgery has failed to control tumor progression.

Keyphrases

systematic review
meta analyses
minimally invasive
randomized controlled trial
poor prognosis
coronary artery bypass
coronary artery disease
atrial fibrillation